Domestic Formulations

Building Indian Brands Since 1989

Since entering the Indian formulations market in 1989, HAB Pharma has built a diverse portfolio spanning cardiovascular care, diabetology, central nervous system disorders, anti-infectives, gastroenterology, respiratory health, dermatology, women’s health, pain management and nutrition.

Several of our brands have been established in the market for decades and continue to grow. This sustained presence reflects our experience across therapeutic categories and our commitment to developing brands that respond to evolving healthcare needs.

Our domestic formulations business brings together brand development, therapeutic expertise and in-house manufacturing capabilities. With direct oversight of our manufacturing processes and quality systems, we maintain accountability across production and supply.

A Nationwide Distribution Network

A strong distribution network is central to making pharmaceutical products accessible across a geographically diverse market. HAB Pharma’s network extends from metropolitan centres to tier-two and tier-three cities and rural markets across India.

With 100+ distributors and 1,000+ stockists, we support product availability across a broad range of markets. Our distribution operations follow Good Storage and Good Distribution Practices, with temperature-controlled warehousing wherever required and GPS-tracked vehicles supporting the movement of products.

A Consistent Pipeline of New Products

Product development is an ongoing part of our domestic formulations strategy. We introduce new products each year, prioritising gaps in our portfolio and emerging therapeutic requirements over incremental line extensions.

Our planned Research and Development Centre in Vasai is intended to strengthen in-house development capabilities and bring research closer to product development and commercialisation. This investment represents the next step in building a broader platform for pharmaceutical innovation.

The Capabilities Behind Our Portfolio

Manufacturing Accountability

Five facilities under our management, supporting direct oversight of manufacturing operations.

Capacity for Consistent Supply

Manufacturing capacity of 3 million+ tablets and capsules per day, supporting production at scale.

Breadth Across Therapeutic Areas

A diverse portfolio spanning major therapeutic areas, backed by experience across multiple healthcare segments.

In-House R&D and Product Development

Our planned R&D Centre, will strengthen in-house product development and support the evolution of our pharmaceutical portfolio.

habpharma